IVI and Bharat Biotech launch Global Chikungunya Vaccine phase-II/III trial in Costa Rica
IVI is advancing clinical development of BBV87 through a phase-II/III randomised, controlled trial to evaluate the safety and…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.